
EDMONTON, Alberta, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company”) today announced the successful completion of a European Union Good Manufacturing Practice ("EU-GMP") audit at its Atholville, New Brunswick cultivation facility. The successful audit reinforces SNDL's ability to participate in regulated international medical cannabis markets and reflects the Company's continued focus on quality, operational excellence, and regulatory compliance.










